Anemia is a widespread disease commonly diagnosed through hemoglobin concentration ([Hb]) thresholds set by the World Health Organization (WHO). However, [Hb] is subject to significant variations mainly due to shifts in plasma volume (PV) which impair the diagnosis of anemia and other medical conditions. The aim of this study was to develop a model able to accurately predict total hemoglobin mass (Hbmass) and PV based on anthropometric and complete blood count (CBC) analyses. 769 CBC coupled to measures of Hbmass and PV using the CO-rebreathing method were used with a machine learning tool in a numeric computing platform (MATLAB regression learner app) to calculate the model. For the predicted values, root mean square error (RMSE) was of 37.9 g and 50.0 g for Hbmass, and 194 ml and 268 ml for PV, in women and men, respectively. Measured and predicted data were significantly correlated (p<0.001) with the coefficient of determination (R2) ranging from 0.73 to 0.81 for Hbmass, and PV, in both women and men. The bland-altman bias between estimated and measured variables was in average of -0.69 for Hbmass and 0.73 for PV. This study proposes a valid model with a high prediction potential for Hbmass and PV, providing relevant complementary data in numerous contexts. This method can notably bring information applicable to the epidemiology of anemia, particularly in countries with high prevalence or in specific population such as high-altitude communities.

The authors have declared no competing interest.

This research received no specific grant from any funding agency.

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

All studies were approved by the local ethics committee (CER-VD, Lausanne, Switzerland) and conducted in accordance with the Declaration of Helsinki.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

The data underlying this article will be shared on reasonable request to the corresponding author.